Tectonic Therapeutic Inc. (TECX)
TECX trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$21.31
-4.65% on the day
Market cap
$416.6M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TECX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001681087 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | NY |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-07-15 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 578 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.1% |
| 1 month | -26.8% |
| 3 months | -31.9% |
| Year to date | 0.0% |
| 1 year | +29.6% |
| From 52-week high | -45.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ZURA | Zura Bio Limited | $4.23 | +5.75% | $405.4M |
| AUTL | Autolus Therapeutics plc American Depositary Share | $1.62 | -6.90% | $431.2M |
| ENTX | Entera Bio Ltd. | $2.49 | -6.04% | $433.1M |
| AGMB | AgomAb Therapeutics NV | $8.81 | -3.08% | $433.9M |
| ALLO | Allogene Therapeutics Inc. | $1.29 | -7.86% | $445.7M |
| EDIT | Editas Medicine Inc. | $2.44 | -11.09% | $375.5M |
| TRXB | TRex Bio Inc. | $13.60 | -3.06% | $373.3M |
| PROK | ProKidney Corp. | $1.57 | -5.99% | $474.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier